AD is a complex disease characterized by multi‐pathological features, in which both Aβ plaques and NFTs are neurotoxic, and optimal approaches for AD treatment might be able to target the most toxic species of both Aβ and tau concurrently. The gene discussed is MAPT; the disease is Alzheimer disease.